Brain Recovery Centers · Concussion Channel

How Spravato Is Different From the Antidepressants That Didn't Work

Serotonin versus glutamate, in plain language.

By the Brain Recovery Centers editorial team · July 11, 2026 · reviewed by Raymond F. Cohen, D.O., Missouri license 36272

If you have tried one antidepressant after another and still feel the weight of depression, it can be tempting to conclude that the problem is you. It is not. Sometimes the medication was aimed at the right target and simply did not connect. Other times, and this is the part that rarely gets explained, the depression may be running on a different system inside the brain than the one those medications were built to reach. Understanding that difference is the first step toward understanding how Spravato works, and why it can help when familiar options have not.

Two different messengers

Most common antidepressants, the SSRIs and SNRIs you have probably heard of, work on serotonin and related chemical messengers. They gently nudge the levels of those messengers over weeks, hoping that the surrounding circuits settle into a healthier pattern. For many people, that approach helps. For a meaningful number of others, it does not, no matter how many are tried or how long they are given.

Spravato (esketamine) works on a different messenger entirely: glutamate. Glutamate is the brain's most abundant excitatory signal, closely tied to how connections between brain cells strengthen, weaken, and reorganize. Ketamine and esketamine act on this glutamate system, and their effects can be measured in hours rather than weeks, opening what researchers describe as a 24 to 72 hour window of heightened neuroplasticity (Zanos and Gould, 2018, Molecular Psychiatry). That is a fundamentally different mechanism from topping up serotonin, which is why it can reach depression that the serotonin-focused medications kept missing.

Why some depression does not respond

Depression is not one single thing with one single cause. The label covers many underlying situations that happen to share similar symptoms. When a depression is driven by problems in glutamate signaling and the plasticity of brain connections, a medicine that only adjusts serotonin has little to grab onto. The person keeps showing up, keeps taking the pills, and keeps waiting for a change that does not come. This is what clinicians mean by treatment-resistant depression, and it is exactly the condition for which Spravato is FDA-approved. It is important to be clear: Spravato is approved for treatment-resistant depression, not for any kind of head injury.

The clue that often gets missed

Here is a pattern that standard care frequently overlooks. If years or even decades ago you got your bell rung - a hard hit in sports, a car accident, a fall, a blast, a fight - that old event can quietly raise your risk for the kind of depression that resists ordinary treatment. People with a bell-ringing hit are more than three times as likely to experience depression, and that elevated risk can persist for years afterward (Beaton et al., 2020, Frontiers in Neurology). Roughly half of people who took a serious hit are not fully back to baseline a year later (TRACK-TBI; Nelson et al., 2019, JAMA Neurology).

This does not mean an old head injury is a reason to take ketamine. A history of a hit is a risk factor for treatment-resistant depression, nothing more and nothing less. But it is a meaningful clue about why the usual approach may have fallen short. Tellingly, a meta-analysis found that antidepressants given after a head impact showed no significant difference from placebo (Foreman et al., 2019, J Head Trauma Rehabil). If that describes your experience, the medication may not have failed because you are beyond help. It may have been aimed at the wrong system.

Other quiet echoes of an old hit

An old head injury tends to leave more than one footprint, and these are worth knowing about because they often travel alongside depression and get treated as separate, unrelated problems:

  • Sleep that never fully repairs. Sleep disturbances affect roughly 30 to 70 percent of people with a head-injury history (Viola-Saltzman and Watson, 2012, Neurologic Clinics), and poor sleep can deepen and sustain low mood.
  • Hormone shifts. Up to about 1 in 6 people develop a hormone deficiency after a hit (pooled prevalence near 16.8 percent after mild injury; Lauzier et al., 2014, Critical Care Medicine), which can quietly mimic or worsen the fatigue and flatness of depression.
  • Symptoms that arrive years later. Because the connection to a decades-old event is easy to miss, the depression is often treated in isolation, without anyone asking what happened long before.

None of these are things to panic over. They are simply signals, and signals are useful. When several of them line up in one person, they point toward looking a little deeper than the standard prescription pad usually allows.

Why the diagnostic lens matters

This is where having neurology available to consult changes the picture. Neurology is a diagnostic capability, a way of asking why standard care may have missed the mark, not a promise of any particular outcome. It means someone can look at your full history, including that old hit you may have stopped thinking about, and consider whether your depression fits the treatment-resistant pattern. At our South County clinic, serving St. Louis County, St. Charles County, and the greater St. Louis area, that lens sits alongside Spravato care under the REMS program and PHQ-9 measurement at every visit, so progress is tracked with numbers rather than guesswork.

The question is not simply which antidepressant to try next. It is whether the depression you are living with runs on the system those antidepressants were designed to reach at all.

If any of this feels close to home, please also know that an old hit is associated with elevated odds of death by suicide (Erlangsen et al., 2018, JAMA). If you are struggling right now, you deserve support today, and you can reach the 988 Suicide and Crisis Lifeline any time by calling or texting 988. You are not a lost cause, and you are not alone in this.

Understanding how Spravato works, on glutamate rather than serotonin, does not by itself tell you whether it is right for you. What it does is open a fairly simple idea: if the usual approach kept missing, maybe it was pointed at the wrong messenger. A proper evaluation from a clinic that has neurology available to consult can look at this carefully, weigh your history and your symptoms together, and help you understand what has actually been going on. That is a calm, clarifying place to start.

If this sounds like you

The connection between an old hit and today's depression is exactly what a clinic with neurology available to consult is built to look at.

Read the concussion channel

A closer look, in the words of people it fits.

Spravato® (esketamine) is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It is not FDA-approved for concussion, traumatic brain injury, or post-concussion syndrome. Use in patients with a concussion history is based on clinical judgment regarding the depression component. We do not offer IV ketamine infusions. This page is educational and not medical advice. Individual results vary.

Safety information

From the SPRAVATO Medication Guide, revised 09/2026. These are excerpts, word for word.

What is the most important information I should know about SPRAVATO?

SPRAVATO may cause serious side effects, including:

How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?

Pay close attention to any changes and tell your healthcare provider right away if you develop any new or sudden changes in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. This is very important when SPRAVATO is started or when the dose is changed.

Tell your healthcare provider or get emergency help right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:

If you're in crisis right now, call or text 988 (Suicide & Crisis Lifeline), or go to your nearest emergency room. Brain Recovery Centers is not an emergency service.

Who should not take SPRAVATO?

Do not take SPRAVATO if you:

If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO.

Before you take SPRAVATO, tell your healthcare provider about all of your medical conditions, including if you:

What should I avoid while taking SPRAVATO?

Do not drive, operate machinery, or do activities that require you to be fully alert and coordinated after taking SPRAVATO. Do not take part in these activities until the next day following a restful sleep.

What are the possible side effects of SPRAVATO?

Increased blood pressure. SPRAVATO can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO and for at least 2 hours after you take SPRAVATO. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO.

Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.

Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.

The most common side effects of SPRAVATO include:

If these common side effects occur, they usually happen right after taking SPRAVATO and go away the same day.

These are not all the possible side effects of SPRAVATO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the full Medication Guide (PDF)

Read the full Medication Guide (PDF)